Amany S Mostafa

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Molecular Docking

Structural Basis

Tyrosine Kinase

Top Venues

Archiv der Pharmazie

Journal of enzyme inhibition and medicinal chemistry

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Eman E Nasr, Samar S Tawfik, Mohammed A M Massoud, Amany S Mostafa
Unveiling new thiazole-clubbed piperazine derivatives as multitarget anti-AD: Design, synthesis, and in silico studies. Archiv der Pharmazie 357 (9) (2024)
Eman E Nasr, Samar S Tawfik, Mohammed A M Massoud, Amany S Mostafa
Unveiling new thiazole-clubbed piperazine derivatives as multitarget anti-AD: Design, synthesis, and in silico studies. Archiv der Pharmazie (2024)
Mohamed A Zeidan, Dina I A Othman, Fatma E Goda, Amany S Mostafa
Identification of novel sulfathiazole-triazolo-chalcone hybrids as VEGFR-2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction. Archiv der Pharmazie (2023)
Dina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, Abdullah A Elgazar, Amany S Mostafa
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mohamed A Zeidan, Dina I A Othman, Fatma E Goda, Amany S Mostafa
Identification of novel sulfathiazole-triazolo-chalcone hybrids as VEGFR-2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction. Archiv der Pharmazie 357 (3) (2023)
Mohamed A Zeidan, Dina I A Othman, Fatma E Goda, Amany S Mostafa
Identification of novel sulfathiazole-triazolo-chalcone hybrids as VEGFR-2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction. Archiv der Pharmazie 357 (3) (2023)
Dina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, Abdullah A Elgazar, Amany S Mostafa
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Dina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, Abdullah A Elgazar, Amany S Mostafa
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Dina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, Abdullah A Elgazar, Amany S Mostafa
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Alaa M Ali, Mohamed A Khalaf, Bhoomendra A Bhongade, Khalid B Selim, Amany S Mostafa
Exploration of antiproliferative potential of modified triazole-benzohydrazone scaffold: Multitarget approach. Archiv der Pharmazie (2023)
Mohamed G Thabit, Amany S Mostafa, Khalid B Selim, Magda A A El-Sayed, Magda N A Nasr
Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity. Archiv der Pharmazie 355 (10) (2022)
Alaa M Ali, Samar S Tawfik, Amany S Mostafa, Mohammed A M Massoud
Benzimidazole-based protein kinase inhibitors: Current perspectives in targeted cancer therapy. Chemical biology & drug design 100 (5) (2022)
Eman E Nasr, Amany S Mostafa, Magda A A El-Sayed, Mohammed A M Massoud
Design, synthesis, and docking study of new quinoline derivatives as antitumor agents. Archiv der Pharmazie 352 (7) (2019)
Amany S Mostafa, Rania M Gomaa, Mohammad A Elmorsy
Design and synthesis of 2-phenyl benzimidazole derivatives as VEGFR-2 inhibitors with anti-breast cancer activity. Chemical biology & drug design 93 (4) (2018)